Back

Interactions between aspirin and ticagrelor during experimental human endotoxaemia

27 August 2023 (12:15 - 12:50)
Organised by: Logo
Congress Presentation Part of: Pharmacology in coronary artery disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor William Parker

University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Optimal antiplatelet therapy for patients after antiplatelet therapy-induced gastrointestinal bleeding: when to resume?
Professor R. Huang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
A meta-analysis on the efficacy of ticagrelor monotherapy after 3 months of dual antiplatelet therapy vs ticagrelor plus aspirin dual therapy on patients with ACS who underwent PCI
Doctor L. Galera (Manila, PH)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of under-dose non-vitamin K antagonist oral anticoagulant with atrial fibrillation undergoing PCI: Insights from a nationwide population-based cohort study
Ms G. Youk (Busan, KR)
Abstract Slides Video
Presentation thumbnail
Interplay among proton pump inhibitors, platelet reactivity and CYP2C19 genotyping in clopidogrel-treated patients after drug-eluting stent implantation
Assistant Professor J. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Effectiveness and tolerability of trimetazidine 80mg once daily in patients with chronic coronary syndrome: the V-GOOD observational study
Professor L. Wolff Gowdak (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacology in coronary artery disease

The Event

Event poster

ESC Congress 2023

27 August 2023 12:15 CET
You may be interested in
thumbnail
Congress Presentation
ANDAMAN - Aspirin twice a day and Acute Coronary Syndrome
thumbnail
Congress Presentation
Ticagrelor monotherapy or DAPT after drug-eluting coronary stenting in patients with or without acute coronary syndrome: a patient-level meta-analysis of randomized controlled trials
thumbnail
Congress Presentation
Variability of the antithrombotic effect of acetylsalicylic acid with the administration of different dosages: reality or myth?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources